TransCode Therapeutics, Inc. Alternatives & Competitors
12 companies similar to TransCode Therapeutics, Inc. — Delivering a cancer-free future
Companies similar to TransCode Therapeutics, Inc.
Curamir Therapeutics, Inc.
Finding RNA-targeted cures for cancer.
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...
Inspirna, Inc.
Converting cancer to a manageable, chronic condition
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Rival Readout
Competing with TransCode Therapeutics, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Bound Therapeutics
Safe and effective next generation RNA therapeutics
Refuge Biotechnologies
DESIGNING INTELLIGENT CELL THERAPIES TO FIGHT CANCER
Inceptor Bio
Advancing Cell and Gene Therapies to Cure Cancer
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Macomics
Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to c...
ImmunoCellular Therapeutics Ltd
Pioneering immune-based therapies to harness the body's defenses against cancer through ad...
About TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. is a biotechnology startup founded in 2016, with a mission to deliver a cancer-free future for all cancer patients. The company focuses on the intelligent design and efficient delivery of targeted therapeutics, particularly TTX-MC138, which targets microRNA-10b, considered the master regula...
Cancer Therapeutics, Targeted Therapies, Biomarker Targeting, RNA-based Therapies, Gene Therapy, Oncology Research, Drug Delivery Technology, MicroRNA-10b, PD-L1 Modulation, CRISPR/Cas9, Cancer Vaccine Development, Tumor Microenvironment, Cancer Treatment Innovation, Precision Medicine, Immunotherapy
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around TransCode Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at TransCode Therapeutics, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.